Case T-370/21: Judgment of the General Court of 6 April 2022 — Biogena v EUIPO — Alter Farmacia (NUTRIFEM AGNUBALANCE) (EU trade mark — Opposition proceedings — International registration designating the European Union — Word mark NUTRIFEM AGNUBALANCE — Earlier EU word mark NUTRIBEN — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

DisplayCustomHeader

Maintenance EN

Please note that this website will be undergoing technical maintenance between 28 and 31 August. Consequently, users may experience instabilities and limited functionality. We apologise for the inconvenience.

Web Content Display (Global)

Publication Detail Actions Portlet

Utilities

Publication Detail Actions Portlet
 Rate this publication

custom-survey-notification

Publication Detail Portlet

Publication detail

Home

Case T-370/21: Judgment of the General Court of 6 April 2022 — Biogena v EUIPO — Alter Farmacia (NUTRIFEM AGNUBALANCE) (EU trade mark — Opposition proceedings — International registration designating the European Union — Word mark NUTRIFEM AGNUBALANCE — Earlier EU word mark NUTRIBEN — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

Case T-370/21: Judgment of the General Court of 6 April 2022 — Biogena v EUIPO — Alter Farmacia (NUTRIFEM AGNUBALANCE) (EU trade mark — Opposition proceedings — International registration designating the European Union — Word mark NUTRIFEM AGNUBALANCE — Earlier EU word mark NUTRIBEN — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

Publication metadata

Pop up window annotations

Publication Viewer

Document viewer

DisplayCustomFooter